This is a US news story, published by MSN.
For more US news, you can click here:
more US newsFor more disease research news, you can click here:
more disease research newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like disease research news, you might also like this article about
new tobacco cessation medication. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Tobacco Cessation news, Tobacco Research news, disease research news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
CytisineMedical Xpress - medical research advances and health news
•
78% Informative
No new tobacco cessation medication has been licensed in the US since 2006 .
Cytisine, a plant-based medication, has been used to treat tobacco dependence for decades in other countries.
It is available as a generic or prescription medication in at least 18 countries, was licensed as an over-the-counter natural health product in Canada in 2017 and became available by prescription in January 2024 .
VR Score
87
Informative language
91
Neutral language
84
Article tone
formal
Language
English
Language complexity
66
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links